Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development

Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a collaboration with Cytiva, a global life sciences leader.

Nuclera and Cytiva collaborate to accelerate characterisation of proteins

Nuclera, the biotechnology company accelerating protein expression and optimisation through its benchtop eProtein Discovery System, has announced a collaboration with Cytiva.

Nuclera and Cytiva Collaborate on Protein Characterization for Drug Development

Nuclera agreed to collaborate with Cytiva to focus on accelerating the production, purification, and characterization of proteins needed for pharma R&D. The collaboration will work with Nuclera’s eProteinTM Discovery System with Cytiva’s Biacore surface plasmon resonance (SPR) technology. Proteins represent 95% of drug targets designed to combat disease, according to Yvonne Tan, PhD, associate director of product management at Nuclera, who expla…

Radyus Research Announces Partnership With Eurofins CDMO Alphora On Drug Development - Canadian Manufacturing

ATLANTA and MISSISSAUGA — Radyus Research, a U.S.-based drug development organization, and Eurofins CDMO Alphora, a Canadian contract development and manufacturing organization, announced a new strategic partnership to try and accelerate early-stage drug development for biotech companies worldwide. By integrating capabilities from preclinical development through clinical proof-of-concept, Radyus and Alphora aim to create a combined services offe…